Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 4
Single-Center, Open-Label Trial to Evaluate the Effect of Lifitegrast Ophthalmic Solution 5.0% on Tear Film Biomarkers in Dry Eye Disease
This is a single-center prospective open-label, clinical trial to explore proteomic expression of tear fluid biomarkers in patients with dry eye treated with L…
Ocular Surface DiseaseDry Eye Syndrome (DES)
Pittsburgh Research InstituteNCT07490535
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of c…
GlaucomaOcular Surface Disease
University of California, Los AngelesNCT04354545
Phase 4
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency
STUDY OBJECTIVE To assess if acoltremon 0.003% improves tear production in patients with Stage 1 Neurotrophic Keratopathy.
Ocular Surface DiseaseNeurotrophic Keratopathy Stage 1
University of South FloridaNCT07502378